Kaleido BioSciences Overview

  • Founded
  • 2015

Founded

  • Status
  • Out of Business

  • Employees
  • 76

Employees

  • Latest Deal Type
  • Out of Business

Kaleido BioSciences General Information

Description

Kaleido Biosciences Inc is a clinical-stage healthcare company. It is focused on leveraging the potential of the microbiome organ to treat disease and improve human health. Its product candidates are Microbiome Metabolic Therapies, or MMTs, which are designed to modulate the metabolic output and profile of the microbiome.

Contact Information

Website
www.kaleido.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Other Pharmaceuticals and Biotechnology
Primary Office
  • 65 Hayden Avenue
  • Lexington, MA 02421
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Kaleido BioSciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Out of Business 08-Apr-2022 00000 Completed Out of Business
4. IPO 28-Feb-2019 0000 00000 00000 Completed Generating Revenue
3. Later Stage VC (Series C) 25-Jun-2018 00000 00000 00000 Completed Clinical Trials - General
2. Early Stage VC (Series B) 18-Sep-2017 $37.1M $41.6M 00000 Completed Clinical Trials - General
1. Early Stage VC (Series A) 13-Aug-2015 $4.5M $4.5M 0000 Completed Stealth
To view Kaleido BioSciences’s complete valuation and funding history, request access »

Kaleido BioSciences Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series C 00,000,000 00.000000 00.00 00.00 00 00.00 00.00
Series B 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series A1 3,057,972 $0.001000 8% $1.69 $1.69 1x $1.69 4.69%
Series A 14,469,180 $0.001000 8% $0.73 $0.73 1x $0.73 22.21%
To view Kaleido BioSciences’s complete cap table history, request access »

Kaleido BioSciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Kaleido Biosciences Inc is a clinical-stage healthcare company. It is focused on leveraging the potential of the microbi
Drug Discovery
Lexington, MA
76 As of 2021
00000
00000000 00 00000

00000

ore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, su
0000000000000
Cambridge, MA
000 As of 0000
00000
000000000 00000

000000

et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ulla
0000000000000
Pasadena, CA
0 As of 0000
00.000
00000000000 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Kaleido BioSciences Competitors (46)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Seres Therapeutics Formerly VC-backed Cambridge, MA 000 00000 000000000 00000
00000000 000000000 Venture Capital-Backed Pasadena, CA 0 00.000 00000000000 00.000
00000000 Venture Capital-Backed Paris, France 00 00000 00000 00000
0000000 0000000000 Venture Capital-Backed Cambridge, MA 000 00000 00000000000 00000
000000 00000000000 Formerly VC-backed South San Francisco, CA 000 00000 00000000 00000
You’re viewing 5 of 46 competitors. Get the full list »

Kaleido BioSciences Patents

  • 49

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 5

    Granted

  • 1

    Pending

  • 000

    Expiring in next 12 mo

Kaleido BioSciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3877825-A1 Flexible display and electronic device including the same Pending 09-Jan-2019 0000000000
US-11197380-B2 Flexible display and electronic device including the same Active 09-Jan-2019 0000000000
US-20200221587-A1 Flexible display and electronic device including the same Active 09-Jan-2019 0000000000
EP-3877825-A4 Flexible display and electronic device including the same Pending 09-Jan-2019 0000000000 0
EP-3877423-A4 Methods of quantifying oligosaccharide preparations Pending 08-Nov-2018 C08B37/0003
To view Kaleido BioSciences’s complete patent history, request access »

Kaleido BioSciences Executive Team (21)

Name Title Board Seat Contact Info
Daniel Menichella Chief Executive Officer & Board Member
Jerald Korn JD Chief Operating Officer, Operations & General Counsel, Legal
Johan van Hylckama Vlieg Ph.D Chief Scientific Officer
William Duke Jr. Chief Financial Officer
You’re viewing 4 of 21 executive team members. Get the full list »

Kaleido BioSciences Board Members (16)

Name Representing Role Since
Anne Prener MD Kaleido BioSciences Board Member 000 0000
Anthony Quinn Ph.D Self Board Member 000 0000
Bonnie Bassler Ph.D Self Board Member 000 0000
Daniel Menichella Kaleido BioSciences Chief Executive Officer & Board Member 000 0000
Geoffrey von Maltzahn Ph.D Self Board Member 000 0000
You’re viewing 5 of 16 board members. Get the full list »

Kaleido BioSciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial